Clinical Trial

Evaluate LAE102 in Healthy and Overweight/Obese Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-07-02; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2024-09-19
Trial Details
NCT Number NCT06493084
Lead Sponsor Laekna Limited
Conditions Overweight and Obese Volunteers
Enrollment 160 participants
Start Date 2024-06-25
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-09